Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials
Shrita Patel
Anne Hickman
Robert Frederich
Susan Johnson
Susan Huyck
James P. Mancuso
Ira Gantz
Steven G. Terra
10.6084/m9.figshare.11982252.v1
https://adisjournals.figshare.com/articles/figure/Safety_of_Ertugliflozin_in_Patients_with_Type_2_Diabetes_Mellitus_Pooled_Analysis_of_Seven_Phase_3_Randomized_Controlled_Trials/11982252
<p>The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p>
2020-03-26 10:15:51
Ertugliflozin
Genital mycotic infection
Sodium-glucose cotransporter 2 inhibitor
Type 2 diabetes mellitus
Urinary tract infection
Volume depletion